PanTher Therapeutics Revenue

Biotechnology Research • Austin, Texas, United States • 11-20 Employees

PanTher Therapeutics revenue & valuation

Annual revenue	$1,539,990
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$5,000,000
Total funding	No funding

Key Contacts at PanTher Therapeutics

Dan Wildman

Independent Director

Tremaine N. Brown

Associate Director Clinical Operations

Margaret Lashof Sullivan

Director Of Research And Development

Company overview

Headquarters	7000 Bee Caves Rd, Ste. 300, Austin, Texas 78746, US
Website	panthertx.com
NAICS	541714
Founded	2016
Employees	11-20
Socials

PanTher Therapeutics Email Formats

PanTher Therapeutics uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@panthertx.com), used 62.5% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@panthertx.com	62.5%
{first name}{last name}	johndoe@panthertx.com	37.5%

About PanTher Therapeutics

PanTher Therapeutics is a clinical-stage oncology company offering transformational localized treatment of cancer. This is accomplished through its proprietary Sagittari™ platform which enables continuous, high-dose treatment of potent oncology agents exclusively at the site of a tumor. The Sagittari™ treatment platform is a revolutionary solution for local administration of therapeutic agents. This foundational technology was invented at the Massachusetts Institute of Technology by PanTher’s founder and CEO. Sagittari is a polymer-based system that allows therapeutic agents to be formulated in a wide range of dosage forms that can be administered to the surface of a cancerous organ or implanted directly into a tumor. The drug product is designed to continuously deliver drug for weeks or months at a desired dose level, without unwanted dose-limiting side effects. PanTher’s lead clinical candidate, PTM-101, has successfully been evaluated in a Phase 1 clinical trial in treatment naïve localized non-metastatic pancreatic cancer patients. PanTher is exploring opportunities to utilize its platform technology in additional solid tumor indications.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Director

Manager

Employees by Department

PanTher Therapeutics has 3 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore PanTher Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-07-06	13	N/A

Funding Insights

Number of funding rounds

PanTher Therapeutics Tech Stack

Discover the technologies and tools that power PanTher Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

Ninja Forms

Form builders

Marionette.js

JavaScript frameworks

Underscore.js

JavaScript libraries

Vimeo

Video players

jQuery UI

JavaScript libraries

Google Maps

Maps

Elementor

Page builders

Microsoft 365

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

Genesis theme

WordPress themes

Frequently asked questions

PanTher Therapeutics is located in Austin, Texas, US.

PanTher Therapeutics generates an estimated annual revenue of $1,539,990. This revenue figure reflects the company's market position and business performance in its industry.

PanTher Therapeutics has an estimated valuation of $5,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

PanTher Therapeutics was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

PanTher Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at PanTher Therapeutics

Dan Wildman

Independent Director

Tremaine N. Brown

Associate Director Clinical Operations

Margaret Lashof Sullivan

Director Of Research And Development

4.8

40,000 users